Blue Trust Inc’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
Blue Trust Inc's HALO Position: Q2 2026 in Review
Blue Trust Inc increased its Halozyme (HALO) stake by 285% in Q2 2026, buying an estimated $7.98K and bringing the position to 158 shares worth $12.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1799.
Blue Trust Inc first reported a position in HALO in Q2 2022 and has held it in 12 quarters since. 668 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- Blue Trust Inc held 158 shares of Halozyme worth $12.4K as of Q2 2026.
- Blue Trust Inc bought 117 Halozyme shares in Q2 2026, an estimated $7.98K.
- Halozyme made up ﹤0.01% of Blue Trust Inc's portfolio in Q2 2026, its #1799 holding.
- Blue Trust Inc first reported a position in Halozyme in Q2 2022 and has held it in 12 quarters since.
- 668 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.